HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Cary W. Akins D. Craig Miller Marko I. Turina Nicholas T. Kouchoukos Eugene H. Blackstone Gary L. Grunkemeier Johanna J.M. Takkenberg Tirone E. David Eric G. Butchart David H. Adams David M. Shahian Siegfried Hagl John E. Mayer Bruce W. Lytle Permission Requests Google Scholar Articles by Akins, C. W. Articles by Lytle, B. W. PubMed PubMed Citation Articles by Akins, C. W. Articles by Lytle, B. W.

Editorials

Guidelines for reporting mortality and morbidity after cardiac valve interventions

^a The American Association for Thoracic Surgery, Beverly, MA, United States
^b The Society of Thoracic Surgeons, Chicago, Il, United States
^c The European Association for Cardio-Thoracic Surgery, Windsor, Berks, United Kingdom

Received 11 December 2007; accepted 11 December 2007.

^_* Corresponding author. Address: Cox 648, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States. Tel.: +1 617 726 8218; fax: +1 617 726 3781. (Email: cakins@partners.org).

Abbreviations: CI = confidence interval

The first 300 words of the full text of this article appear below.

Since the initial publication of ‘Guidelines for Reporting Morbidity and Mortality After Cardiac Valvular Operations’ in 1988, [1] followed by a revised version in 1996 [2], valvular heart surgery has evolved to include an enhanced understanding of patient- and disease-related factors affecting outcomes, increased numbers of valve repairs, more operations performed for patients with minimal symptoms, new prostheses, novel repair methods, and the emergence of percutaneous interventional (catheter-based) valve repair and replacement. To adapt to this changing environment, the Councils of the American Association for Thoracic Surgery, The Society of Thoracic Surgeons, and The European Association for Cardio-Thoracic Surgery have directed an Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity to review current clinical practice to update and clarify these reporting guidelines. The guidelines are intended to cover treatment of all four cardiac valves in both adult and pediatric patients. Further, these guidelines apply uniformly, irrespective of whether the therapy was carried out as a conventional open operation, as a minimally invasive (video-assisted or robotic) surgical procedure, or with percutaneous interventional catheter techniques.

1. Purpose

These reporting guidelines are intended to facilitate analysis and reporting of clinical results of various therapeutic approaches to diseased heart valves such that meaningful comparisons can be made and inferences drawn from investigations of medical, surgical, and percutaneous interventional treatment of patients with valvular heart disease.

2. Early mortality

Early mortality is to be reported as all-cause mortality at 30, 60, or 90 days and depicted by actuarial estimates (with number remaining at risk and confidence intervals [CIs]) or as simple percentages, regardless of the patient's location, be it home or in a health care facility.

3. Definitions of morbidity

3.1 Structural valve deterioration
Structural valve deterioration includes dysfunction or deterioration involving the operated valve (exclusive of infection or thrombosis), as determined by reoperation, autopsy, or clinical investigation. Clinical investigation should include periodic . . . [Full Text of this Article]